What Is Wegovy and How Is It Used?
Wegovy (semaglutide) is an injectable prescription medication approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults with obesity or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which help regulate appetite and food intake. Wegovy is used alongside a reduced-calorie diet and increased physical activity. Medicare may provide coverage in certain circumstances, primarily when the drug is medically necessary for conditions such as type 2 diabetes or obesity-related comorbidities.
How Medicare Part D Covers Prescription Drugs Like Wegovy
Original Medicare (Parts A and B) does not cover most weight-loss medications, including Wegovy. However, Medicare Part D, the prescription drug plan offered through private insurers approved by Medicare, often covers Wegovy. Coverage depends on the specific Part D plan’s formulary, or list of covered medications, and its associated cost-sharing rules. Most people with Medicare enroll in a Standalone Part D Plan (PDP) or receive prescription drug coverage through a Medicare Advantage Plan (MA-PD). If Wegovy is on the plan’s formulary and is covered under the medical benefit rather than the pharmacy benefit, cost-sharing may differ. Plans typically place drugs on tiers that determine copay or coinsurance amounts. Prior authorization or step therapy requirements may also apply.
Key Medicare Part D Terms to Know
- Formulary: A list of medications covered by a Part D plan.
- Tier: A cost-sharing level that influences your copay or coinsurance.
- Prior Authorization: Approval your plan requires before covering a medication.
- Step Therapy: A process where you try lower-cost drugs before the plan covers Wegovy.
- Medical Necessity: Coverage rules that may allow Medicare to pay for certain drugs used for conditions like diabetes.
Typical Wegovy Costs with Medicare Part D
Wegovy is typically dispensed as a multi-dose pen with varying doses. The cash price is high, often over $1,000 per week without insurance; however, Medicare Part D can substantially reduce what you pay. Your out-of-pocket cost depends on several factors, including your plan’s formulary tier for Wegovy, whether you have reached your deductible, your coinsurance or copay amount, and whether the drug requires prior authorization or step therapy. Some plans may cover Wegovy with a moderate copay after the deductible is met, while others may require coinsurance percentages that can still lead to significant patient costs.
Illustrative Medicare Part D Cost Examples for Wegovy (Monthly Estimates)
| Plan Feature/Benefit Level | Verified Detail | Source Type |
|---|---|---|
| Monthly Retail Cash Price (no insurance) | $1,300–$1,700 (varies by pharmacy and dose) | Pharmacy pricing databases |
| Plausible Medicare Part D Copay After Deductible | $20–$80 per fill depending on tier | Formulary samples from major national plans |
| Coinsurance Example (40% after deductible) | $400–$600 per month on a $1,000–$1,500 allowed amount | Illustrative based on typical plan cost-sharing |
| Manufacturer Savings Programs | May reduce out-of-pocket costs to $0 for eligible, commercially insured patients; Medicare generally does not permit manufacturer coupons | Program terms and Medicare policy |
| Annual Out-of-Pocket Maximum (Medicare Part D) | $8,000 (2024 limit, adjusted annually) | CMS annual announcement |
Steps to Find Wegovy Coverage and Lower Your Costs
To understand how your specific Medicare prescription drug plan covers Wegovy, start by checking the plan’s formulary on medicare.gov or your plan’s website. Search for semaglutide or Wegovy and review the tier, cost-sharing, and any prior authorization requirements. If Wegovy is not covered or is on a high tier, consider these options: speak with your healthcare provider to submit a prior authorization request documenting medical necessity, request an exception from your plan, or explore whether other GLP-1 agonists on a lower tier may be appropriate. Compare plans during Annual Enrollment (October 15–December 7) if you have Medicare Advantage or Part D, as formularies and costs can vary significantly.
Action Checklist to Reduce Wegopy Costs with Medicare
- Check your Part D formulary for semaglutide or Wegovy.
- Confirm whether prior authorization or step therapy is required.
- Review your plan’s deductible and coinsurance/copay structure.
- Ask your provider for documentation of medical necessity for weight management or related conditions.
- Use the Medicare Plan Finder to compare plans annually.
Manufacturer Support and Important Limitations with Medicare
Novo Nordisk, the manufacturer of Wegovy, offers patient assistance programs that can reduce or eliminate costs for eligible uninsured or underinsured individuals. However, Medicare rules generally prohibit the use of manufacturer copay coupons for drugs covered by Medicare Part D. This means that if you have Medicare, you typically cannot use these savings programs to lower your share of costs. Medicaid rules vary by state and may differ; some state Medicaid programs may cover Wegovy under specific clinical criteria. Always confirm current eligibility and rules directly with the manufacturer and your Medicare plan before relying on manufacturer discounts.
Out-of-Pocket Maximums and Financial Assistance
Once you and your plan have spent a combined total of $8,000 (the 2024 Medicare Part D out-of-pocket maximum), your plan must cover 100% of covered drugs for the rest of the year. Until then, costs can vary widely based on whether you are in the coverage gap (donut hole) or catastrophic coverage phase, and how your plan applies discounts. If Wegovy is not covered or if your share remains prohibitive, discuss financial hardship options with your provider and contact your plan to request an exception. Some plans may offer supplemental benefits or case management for chronic conditions that include obesity, which could help coordinate care and lower costs.
Bottom Line and Practical Takeaways
Wegovy is generally covered under Medicare Part D, but your out-of-pocket costs depend heavily on your specific plan’s formulary tier, deductible status, and rules such as prior authorization or step therapy. Estimated monthly costs can range from a modest copay to several hundred dollars in coinsurance before reaching the Part D out-of-pocket maximum. You can lower expenses by reviewing your plan’s formulary, working with your provider on prior authorization, comparing plans during enrollment periods, and understanding manufacturer assistance limitations under Medicare. For personalized details, contact Medicare directly or review your plan’s documents for formulary specifics, coverage rules, and cost-sharing details.
Frequently Asked Questions
- Does original Medicare cover Wegovy? Original Medicare (Parts A and B) typically does not cover weight-loss medications like Wegovy. Coverage is generally available through Medicare Part D prescription drug plans.
- Can I use a Wegovy manufacturer coupon if I have Medicare? No. Medicare rules generally do not allow manufacturer copay assistance for drugs covered under Part D. These coupons usually cannot be applied.
- What if my plan denies Wegovy coverage? Your provider can submit a prior authorization request with medical documentation. You may also request an exception from your plan or ask about alternative covered medications.
- When can I change my plan to get better Wegovy coverage? The Annual Enrollment Period (October 15 to December 7 each year) allows you to switch Medicare Advantage or Part D plans. Special Enrollment Periods may apply under certain circumstances.
- Does Medicaid ever cover Wegovy? Medicaid coverage varies by state and may be available under certain clinical criteria. Check with your state Medicaid agency for specific policies and requirements.